Sagimet Biosciences Inc.

NASDAQ:SGMT

Biotechnology

Healthcare
$10.11 +1.38%

+$0.09 today

Market cap
$711.15M
Beta
3.44
P/E (TTM)
-5.0
EPS (TTM)
-$1.34
52W Low $4.50High $11.41

Volume 0.93M

Average 1.49M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$56.89M

FY 2025 · Annual

Net Income

-$51.04M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue002M00
Cost of Revenue00000
Gross Profit002M00
Gross Margin——100.0%——
Research & Development19.34M24.92M19.78M38.44M39.05M
Selling, General & Admin4.38M6.14M12.96M16.01M17.84M
Operating Expenses23.72M31.06M32.74M54.45M56.89M
Depreciation & Amortization0130K000
EBITDA(24.44M)(30.37M)(27.88M)(45.57M)(51.04M)
EBITDA Margin——-1393.8%——
Operating Income(23.72M)(31.06M)(30.74M)(54.45M)(56.89M)
Operating Margin——-1537.0%——
Interest Income26K553K2.86M8.89M5.85M
Interest Expense00000
Other Income / Expenses(723K)556K2.86M8.89M5.85M
Income Before Tax(24.44M)(30.5M)(27.88M)(45.57M)(51.04M)
Pre-Tax Margin——-1393.8%——
Income Tax Expense00000
Net Income(24.44M)(30.5M)(27.88M)(45.57M)(51.04M)
Net Margin——-1393.8%——
EPS (Basic)(1.10)(1.38)(1.53)(1.45)(1.58)
EPS (Diluted)(1.10)(1.38)(1.53)(1.45)(1.58)
Weighted Avg Shares22.17M22.17M18.19M31.35M32.35M
Weighted Avg Shares (Diluted)22.17M22.17M18.19M31.35M32.35M

SGMT Earnings Waterfall · TTM

NASDAQ:SGMT · Revenue to Net Income

Key Ratios

EPS$-1.35
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.8
P/S Ratio0.0

Analysis

$0 of revenue converted into -$43.5M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.35, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
8-KCurrent reportOct 22, 2026
SC 13GSC 13G filingOct 7, 2026

How much revenue does SGMT generate?

Sagimet Biosciences Inc. (SGMT) reported $0.00 of revenue in fiscal 2025.

Is SGMT profitable?

Sagimet Biosciences Inc. (SGMT) reported -$51.04M of net income.